chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After receiving  his second covid vaccine, there was a tiny black dot left on his right thigh. This was reported to VAERS after his first dose of the covid vaccine. Since this event, we have changed needles and have not had another reported incidence.
Initially after the shot, I had tightness running up into my neck behind my ear in the sternocleidomastoid muscle and arm in general.  Over the next few hours, I experienced left sided numbness and tingling to parts of my face (forehead, cheek, lip, chin), my arm and hand (shoulder down to finger tips) lasting all overnight and finally went away in the morning.  Then I had a painful swollen supraclavicular lymphnode that did not go down for about 4 days.
Hx of HTN, Baseline BP 140/90, did not take BP meds the night prior. Reported dizziness, BP 169/114 HR73 RR18, then second reading 153/109 HR83 RR18, left in stable condition
Case number PHEH2012US019569 is an initial spontaneous report received from a nurse on 30 Sep 2012. This report refers to a 12-years-old female patient whose medical history and concomitant medications were not reported. It was reported that she received only the MenA lyophilized conjugate vaccine component of MENVEO (batch number: 11042) reconstituted with sterile water intramuscularly and did not receive MenCYW-135 liquid conjugate component on 30 Sep 2012. No adverse reaction was reported.
First 12 hours felt great. During the next 24 hours, experienced blurry vision, Intense Joint/Muscle Aches Pain. Complaint of cognitive fog. Fatigue. Symptoms previously experienced with self reported Long covid.
Patient presented to pharmacy on 9/24/20 after vaccine was administered on 9/23/20. His left arm shows redness and slightly swelling area with a diameter of approximately 2-3 inches. Patient was recommended to use cold compress to reduce redness and swelling as well as topical antihistamine. Patient denied feeling ill due to vaccine, asked for sign and symptoms of fever, difficult breathing, headache which were all denied by patient.
Immediately rash broke out around the vaccine site. BENADRYL 1 tsp administered for reaction. Monitored for observation discharged after 15 min successful observation by P.A.
Broke out in a rash with hives. Injection site red and with hive; at urgent care center given injection of Benadryl.
the day p/recv vax pt exp inj site swelling & erythema from the inj site to below the elbow; by 9/8/98 pt had recovered from exp
severe unrelenting diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (severe unrelenting diarrhea) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced DIARRHOEA (severe unrelenting diarrhea). At the time of the report, DIARRHOEA (severe unrelenting diarrhea) outcome was unknown.            After 2nd dose, she states that she didn't saw that on the side effects list and is wondering if this is a side effect of the vaccine and What can she take. First dose of the vaccine was received 28 days before 23/MAR/2021 and had no side effects.  No concomitant medication details were provided. No treatment medication details were provided.
Recently complaining of arm pain and having to use the other arm to lift the arm that the injection was made into.  The pain started after receiving the covid vaccine.
Patient reported arm has been very painful since the evening/night of receiving the shot and he is so painful that he is unable to raise his arm.  Patient stated they would be going to the doctor to get checked out
She experienced a localized reaction after Zostavax vaccine. She had excessive redness and swelling from shoulder down to her elbow. She was tired and weak.
The patient said she had a seizure the day after she got her covid (Spikevax) vaccine. She is already prone to seizures and is on multiple seizure medications. She went to the hospital and they told her just to notify us. She said they filled out this form but I was not sure so I wanted to make sure it was reported.
temperature excursion that exceeded the stability data documented in the local labelling and additional supporting stability data.these vaccines were administered with no reported ae; Initial information was received on 03-Aug-2023 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves 11 years old female patient who reported that the temperature excursion that exceeded the stability data documented in the local labelling and additional supporting stability data.these vaccines were administered with no reported ae after receiving diphtheria-2/tetanus/5 ac pertussis vaccine [Adacel].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of 0.5 ml of suspect diphtheria-2/tetanus/5 ac pertussis vaccine (Suspension for injection) (strength, expiry date, lot number not reported) via intramuscular route in unknown administration site for Immunization for temperature excursion that exceeded the stability data documented in the local labelling and additional supporting stability data.these vaccines were administered with no reported ae (poor quality product administered) (latency : same day). The information on batch number was requested.  Action taken was not applicable.  At time of reporting, the outcome was Unknown for the event temperature excursion that exceeded the stability data documented in the local labelling and additional supporting stability data.these vaccines were administered with no reported ae.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Patient states she had a "weird reaction" and had generalized bone pain and " severe burning." She states her symptoms also included headache and fever (does not know the temp) which lasted for one full day. States she took aceteminophen and that helped her some; she contacted her Oncologist and asked her to report those SE to us.
A couple hours after the vaccination, I felt my head starting to ache. Then later I felt like there  was an elephant on my chest. I  was having difficulty breathing. My body started to ache. I went to bed thinking it would go away. the next morning it  was worse so I called the doctor. He  said to go on bed rest and call the next day if it was not better. This day 2 days after I feel better, but no good and have a severe stomach and diarehha.
Ordered vaccine was MCV4 (Menactra) which should have been given at 11 year visit. Men B (Trumenba) was mistakenly given instead. No ill effects from vaccine, however error was not noticed until 13 year old visit and was given Menactra at that time.
Prolonged severe headache, fatigue, chills, muscle aches, nausea/vomiting for 5 days after injection.
Information has been received from an office manager referring to multiple patients of unknown age and gender. On unknown dates, the patients were vaccinated with improperly stored PROQUAD (rHA, lot # m001150, expiration date 05-JUL-2017, route unknown). The vaccine had been stored under the temperature of 21.7 Fahrenheit. There was no previous temperature excursion and no date logger involved. No adverse effects were reported. This is one of two reports received from the same reporter. Additional information has been requested.
Uncontrollable chills. Starting Wednesday the 9th at ~7PM until Thursday the 10th at ~11AM Extreme fatigue. Starting Wednesday the 9th at ~7PM until Sunday the 13th at ~2PM Loss of bowel control, diarrhea, and digestive pain. Starting Thursday the 10th at 4PM until Sunday the 13th at ~2PM.
Case number PHEH2012US021619 is an initial spontaneous report received from a nurse on 26 Oct 2012. This report refers to a 21-years-old female patient. It was reported that on 26 Oct 2012 she only received a 0.5 ml intramuscular dose of MenCYW-135 liquid conjugate component of MENVEO (batch number: 123123, expiry date: Jun 2013) instead of being reconstituted with MenA. No adverse reaction was reported.
About 7 months after injection, I had a sudden onset to preeclampsia that led to an eclamptic seizure. Had to have an emergency c section at 28 weeks. Baby did survive. I was hospitalized for an additional 5 days to stabalized blood pressure. It took about 5 weeks for blood pressure to come back to normal.
admitted 5/12 for management of acute hypoxic respiratory failure secondary to COVID pneumonia.
Pt presented to the ED after a syncopal episode at home. Pt was on the toilet having a bowel movement when he developed sudden-onset nausea, light-headedness, and dizziness. He felt that he was going to pass out and his daughter came into the room and helped him. He did not lose consciousness or hit his head. Symptoms resolved "several minutes later." Pt complains of new-onset heartburn. Pt states that the symptoms he felt during the episode were similar to the sensation he felt during a heart attack he had several years ago.
Areas of local induration with hyperesthesia surrounding vaccine site. Circular, red, warm, very tender.
was left in the freezer longer than 14 days; was left in the freezer longer than 14 days; has a red circle on her arm with the size of orange; early pregnant; This is a spontaneous report from a contactable consumer (Patient's husband). This consumer or other non hcp reported information for mother. This is a maternal report. A Pregnant female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported), dose 2 via an unspecified route of administration in Sep2021 as DOSE 2, SINGLE for covid-19 immunisation . The patient medical history and concomitant medications were not reported. The patient was early pregnant (maternal exposure timing unspecified) in 2021, It was stated that "was left in the freezer longer than 14 days" in Sep2021, has a red circle on her arm with the size of orange in Sep2021. The mother reported she became pregnant while taking bnt162b2.It was further stated that "his wife who received the second dose of the Pfizer Biontech COVID19 (Comirnaty) vaccine two weeks ago and on Saturday, his wife received a phone call from the location where she got the shot. The pharmacist told her that the protocol of storing the vaccine in the freezer for 14 days were not followed and was left in the freezer longer than 14 days. Caller said that his wife was early pregnant and was concerned with potential AE or issues with the administration of the vaccine. Caller stated that there was "nothing weird" but mentioned that his wife has a red circle on her arm with the size of orange for few days. Caller expressed that they are a little nervous hence they are calling for confirmation for any potential issues". The outcome of has a red circle on her arm with the size of orange was unknown.   The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Allergy and red in the right deltoid arm. Treatment - BENADRYL 50 mg q 6 hr prn, put ice bag in this area; call in two days.
Rashes on face and legs and generalized itching, patient took BENADRYL 25mg Tablets - 1 tab q 4-6 hr. prn : Recovered in two days.
RIGHT NECK IS STIFF AND PAINFUL, THROAT PAIN, HEADACHE, NAUSEA, CHILLS
The patient experienced no symptoms; patient was administered an improperly stored dose of PROQUAD; This spontaneous report was received from a medical assistant, and refers to a patient of unknown age and gender. Information about the patient's medical history, concurrent conditions and drug reactions or allergies was not provided.      On 01-JUN-2020, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (lot # S035108, with an expiration date in 03-MAY-2021), that underwent a temperature excursion of 7.9 degrees Fahrenheit, during a time frame of 1 hour an 8 minutes, for prophylaxis (strength, dose and route were not provided). The diluent used for administration of the dose was properly stored. Digital data logger was involved, however it was reported that there was no previous temperature excursion. The patient experienced no symptoms.
It has been eight days since the vaccination and noticed I was itchy at the spot, red, swollen? Several hives present.
Patient got a rash, which was reported to our pharmacy by the physician's nurse. Nothing was prescribed for him; they just called to let us know.
chills,flu like symptoms.  PT presents with burning sensation in chest with tightness and SOB x Saturday denies cough. Reports receiving 2nd moderna vaccine Tuesday prior to onset with hx of covid 10/2020. 43 yo m c/o acute atraumatic onset of substernal cp 'burning' sensation and difficulty breathing w/dry cough x24hrs states sx's feel similar to when he had COVID19 back in Oct2020; Pt states that then he was successfully tx'd w/hydroxychloriquine+azithromycin+zinc by civilian provider; initially dx'd w/covid and went in for tx after he woke up 'feeling like I was drowning' 48hrs s/p dx; Pt states burning sensation 'somewhat' similar to that episode; Pt recently received covid19 vaccine w/2nd dos
Patient came to pharmacy on 11-10-2021 to receive Dose 2 of Moderna. Upon reviewing her screening form, the patient told me she had a rash about 4 hours after getting her first dose on 10-13-2021. The rash was on her legs and described as being pin-point in nature and very itchy.  At the time, she tried taking Benadryl for several days but it wasn't helping. Patient states she kept itching the area, causing it to turn red in appearance and caused some spots to bruise.  On 10-18-2021, she went to her Dr and was prescribed oral hydroxyzine tablets which helped her itching and the rash eventually disappeared.
Shingles. Began as a back ache, ache continued and developed into feeling of deep skin irritation. Spanning from center of back, around rib cage, to sternum. Visible rash present 10/16/2016, cluster of raised bumps, 2 inch diameter. Pain increased and became concerning.  Diagnosed with shingles on 10/21/2016 at an Urgent Care facility. Prescribed acyclovir for 7 days and a MEDROL dose pack.  Majority of symptoms have resolved, minor pain in rib cage and visible rash remains but asymptomatic as of 11/4/2016.
pt recv vax & was looking for information concerning the effectiveness of the vax if it was given IM & was not reporting any adverse rxn;
Patient called 10.20.2023 saying her face was swelling from the covid vaccine. She noted since yesterday afternoon. Vaccine was administered 10/18/2023 at 5:45. She said she had allergy. I informed her about seeing doctor and she has visit today. She called for name of vaccine and I gave her name of vaccine. Using this information she will go to doctor and get treated for her swelling.
administered vaccine which expired; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a patient who received HAB (Twinrix adult) (batch number X239D, expiry date 7th August 2022) for prophylaxis.   Co-suspect products included hepatitis A and hepatitis B vaccine pre-filled syringe device (Twinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 8th August 2022, the patient received Twinrix adult and Twinrix Pre-Filled Syringe Device. On 8th August 2022, unknown after receiving Twinrix adult and Twinrix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 08-AUG-2022 Reporter's Comments: The patient received Twinrix vaccine today which expired the day before reporting on 7th Aug 2022. The patient wanted to know if the vaccine needs to be repeated or this dose be considered viable. The reporter did not provide additional information due to email inquiry. The reporter consent to follow up. The address was in the health care professional profile but not verified with health care professional. Email address was correct. Additional Supportive Information: The patient received an expired dose of Twinrix vaccine, which led to expired vaccine used.
Injection site sore; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Injection site sore) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Injection site sore). At the time of the report, VACCINATION SITE PAIN (Injection site sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medication were reported.  No treatment medication were reported.
I'm still crippled up I can't make a fist with my right or left hand; Excruciating pain; This case was reported by a consumer via media and described the occurrence of movement disorder in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   In December 2020, the patient received Shingles vaccine. On an unknown date, less than 9 months after receiving Shingles vaccine, the patient experienced movement disorder (serious criteria disability) and pain. On an unknown date, the outcome of the movement disorder and pain were not recovered/not resolved.   It was unknown if the reporter considered the movement disorder and pain to be related to Shingles vaccine.  Additional details were provided as follows The patient had reported for him/herself. The age at vaccination was not reported. The patient was still crippled up at the time of reporting. The patient could not make a fist with right or left hand and had excruciating pain. The patient had all the symptoms of rheumatoid arthritis but had been tested and had not rheumatoid arthritis. The same symptoms were equal to that of heavy metal poisoning which he/she was tested for and there was no sign of the poisoning. The patient stated that, what the heck did the shingles vaccination do for him/her. The patient filed a complaint with the CDC and had not heard back from anyone till the time of reporting.
Swelling and redness and erythema at injection site and above, headache. Nausea at first but has subsided.
pt recv vax; erythema 7cmx11cm, RA at inject site; motrin given;
Daily Severe headaches, blurred vision, sensitivity to light, muscle pain, weakness, fatigue, extremely heavy period, brain fog
patient received vaccine 10/9/2020; called today and reported continuing arm pain and limited mobility with arm of injection. Filled out incident/adverse report 1723
Fever, fatigue, severe muscle aches for 2 days. 2 days after vaccine, became short of breath and felt chest tightness,.
TOOK AN UNREFRIGERATED DOSE; This spontaneous case report was received from a consumer (PVX2019-042) on 04-Jan-2019. The report describes a 49-year-old male consumer who "took an unrefrigerated dose". The consumer was receiving Vivotif capsule (lot number: 3003238) for an unknown indication.  It was reported that the consumer took the first dose of Vivotif that was unrefrigerated for 24 hours.  The action taken with Vivotif with respect to the event "took an unrefrigerated dose" was not applicable.  The clinical outcome of the event "took an unrefrigerated dose" was unknown.  Company's Comment: The causality of the event "took an unrefrigerated dose" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took an unrefrigerated dose" was considered as not applicable.
My daughter, who is the most normal kid around, is telling me that she is scared of being alone because she is afraid something or someone will attack her. She has never had delusions or hallucinations before, and is now one week after her first dose of the Pfizer vaccine. She is scared now to walk down the hallway in the house sometimes and also to be alone in her room or another room in the house without people. She was in virtual school for the entire school year and never had a situation like this. She is scared she will never stop feeling this way. The only thing that has changed in her life and is different is that she got the vaccine.
Temp excursion for 15 vials/supposed to be discarded last Jan1,2022; This spontaneous case was reported by a health care professional and describes the occurrence of PRODUCT STORAGE ERROR (Temp excursion for 15 vials/supposed to be discarded last Jan1,2022) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041J21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Jan-2022, the patient experienced PRODUCT STORAGE ERROR (Temp excursion for 15 vials/supposed to be discarded last Jan1,2022). On 03-Jan-2022, PRODUCT STORAGE ERROR (Temp excursion for 15 vials/supposed to be discarded last Jan1,2022) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment and concomitant medications were provided.  Action taken with mRNA-1273 in response to the event was not applicable.
Headache; injection side pain; tiredness; feeling unwell; This is a spontaneous report from a non-contactable physician, the patient. A 62-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 07Apr2021 (at the age of 62-year-old) as a single dose for COVID-19 immunisation. Medical history included factor V Leiden mutation (reported as Modification of Factor 5 Type Leiden). Concomitant medications were not reported. The patient did not have any allergies to food, medications, or other products. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 17Mar2021 (at the age of 62-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021, the patient experienced headache, injection side pain, tiredness and the patient was feeling unwell. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events headache, injection side pain, tiredness and feeling unwell was recovering at the time of this report.  No follow-up attempts are possible. No further information is expected.